<Anchor>

President Trump said that it was a breakthrough in the treatment of Corona 19 on the 24th, and announced that the FDA of the US Food and Drug Administration had urgently approved plasma treatment. I'm getting up.

Correspondent Kim Soo-hyung reports from Washington.

<Reporter>

This is a public reflection posted on Twitter by the director of the US Food and Drug Administration.

He said he should have been able to accept the criticism poured on him and that he should have properly explained that the risk of reduction through plasma therapy is relative, not absolute.

President Trump confessed that he exaggerated the data when he announced that the U.S. FDA had urgently approved plasma treatment and opened a breakthrough in the treatment of COVID-19.

[Steven Korea/US FDA Director (Yesterday): 35 out of 100 people show data that plasma treatment results can save lives. This is of great importance to patients and families.]

Criticism from health experts has been pouring out that the 35% reduction in mortality is not sure where it came from.

[Ash Ja/Harvard University Professor: This is a very misrepresentation of the data. These things make me worry that the FDA's scientific review process has been broken.] At the

Republican Convention, praise that the FDA urgently approved plasma treatment to open a new breakthrough in corona treatment continued.

As criticism pours over whether the FDA has succumbed to President Trump's political pressure, concerns have also been raised over whether the vaccine is being screened.